Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trial

Diabetes, Obesity and Metabolism, 01/28/2011

The combination of once–daily insulin detemir (IDet) with sitagliptin (SITA) showed a clinically and significantly better improvement in glycaemic control than SITA in combination with or without sulphonylureaS (SUS).

Print Article Summary Cat 2 CME Report